- Home
- ATYR vs MRT Comparison
ATYR vs MRT Comparison
Compare ATYR & MRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- MRT
- Stock Information
- Founded
- ATYR 2005
- MRT 2018
- Country
- ATYR United States
- MRT Turkey
- Employees
- ATYR N/A
- MRT N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- MRT Rental/Leasing Companies
- Sector
- ATYR Health Care
- MRT Consumer Discretionary
- Exchange
- ATYR Nasdaq
- MRT Nasdaq
- Market Cap
- ATYR 306.2M
- MRT 228.0M
- IPO Year
- ATYR 2015
- MRT N/A
- Fundamental
- Price
- ATYR $5.13
- MRT $2.91
- Analyst Decision
- ATYR Strong Buy
- MRT Strong Buy
- Analyst Count
- ATYR 6
- MRT 2
- Target Price
- ATYR $20.20
- MRT $6.00
- AVG Volume (30 Days)
- ATYR 3.6M
- MRT 105.7K
- Earning Date
- ATYR 08-12-2025
- MRT 01-01-0001
- Dividend Yield
- ATYR N/A
- MRT N/A
- EPS Growth
- ATYR N/A
- MRT N/A
- EPS
- ATYR N/A
- MRT N/A
- Revenue
- ATYR N/A
- MRT $18,659,655.00
- Revenue This Year
- ATYR $960.85
- MRT $83.29
- Revenue Next Year
- ATYR $1,283.47
- MRT $106.66
- P/E Ratio
- ATYR N/A
- MRT N/A
- Revenue Growth
- ATYR N/A
- MRT N/A
- 52 Week Low
- ATYR $1.48
- MRT $1.32
- 52 Week High
- ATYR $5.98
- MRT $3.89
- Technical
- Relative Strength Index (RSI)
- ATYR 55.98
- MRT 55.58
- Support Level
- ATYR $4.78
- MRT $2.45
- Resistance Level
- ATYR $5.50
- MRT $3.15
- Average True Range (ATR)
- ATYR 0.37
- MRT 0.18
- MACD
- ATYR -0.09
- MRT 0.06
- Stochastic Oscillator
- ATYR 36.12
- MRT 77.30
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About MRT Marti Technologies Inc.
Marti Technologies Inc is a mobility app, offering multiple transportation services to its riders. Marti operates a ride-hailing service that matches riders with car, motorcycle, and taxi drivers, and operates a large fleet of rental e-mopeds, e-bikes, and e-scooters. All of Marti's offerings are serviced by proprietary software systems and IoT infrastructure.